Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential ...

Brazilian researchers have taken an important step toward precision medicine by identifying four genes that can predict which melanoma patients will not respond to immunotherapy. Although this ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

A Bristol Myers Squibb immunotherapy currently approved as a first-line treatment for metastatic melanoma has failed a pivotal clinical trial intended to support expanding the therapy’s use to keeping ...

Metastatic kidney tumors disappearing for good. When the Food and Drug Administration approved the first immunotherapy for cancer in 2011, it ushered in a new era for care. Patients had a reason for ...

Share on Pinterest The artificial sweetener sucralose may be linked to reduced effectiveness in immunotherapy for treating some types of cancers. Cavan Images/Getty Images Non-sugar, or artificial, ...